VASO Company Profile and Key Details

Vaso Corporation last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.32. This means the shares are trading below this model’s fair value.

The stock is currently mid-range between its 52-week high and low $0.11 and $0.21. With a market capitalization of about $29.91 million, Vaso Corporation is classified as a micro-cap and shows lower-than-market volatility (beta ~0.74). Key stats such as the average daily volume over the past year has been around 175.99 thousand shares, volume is running light vs its 52-week average. Headquartered in Plainview, NY, Vaso Corporation operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Jun Ma, the company employs approximately 298 people and listed since August 18, 1995. Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally.

Vaso Corporation trades at a P/E ratio of 11.55, slightly below the S&P 500 average, with a price-to-sales ratio of 0.34 and a price-to-book ratio of 1.06 suggesting the stock is closer to book value. The P/FCF stands at 3.4, also above market averages.

Valuation shows Vaso Corporation trading at a premium to the broader market with a P/E of 11.55.

Our AI price prediction model suggests that Vaso Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.